senestech.com (SNES) - Projected Sales Volume

SenesTech, Inc. (SNES) protects food hubs from pests, maintaining the profitability of agrologistics. The development of ContraPest humane biotechnologies replaces toxic poisons with eco-friendly solutions. The projected sales volume trend on GURU.Markets reflects a resilient base, where the parameter value reaches 0.00. Diversification through non-toxic rodent control minimizes risks within the food industry and urban environments.

SNES - SenesTech, Inc. Company Future Sales Volume over the range 07/04/2022 - 11/13/2026

Financial and market metric breakdowns for SenesTech Corp (SNES)

- current price and projected stock value:

Stock Quotes SenesTech, Inc.|SNES - Analyst Forecast Prices

- market capitalization indicators:

Market Capitalization SenesTech Inc.|SNES - Total Enterprise Value

- book capitalization information:

Book Value per Share SenesTech|SNES - Company Net Assets|Market Capitalization to Book Value Ratio senestech.com|SNES - Aggregate Asset Value

- debt level and financial liquidity data:

- earnings and market ratios statistics:

SNES - Net Financial Result|Expected Profit SenesTech, Inc.|SNES - Business Payback Period|Future Price to Earnings SenesTech, Inc.|SNES - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple SenesTech Inc.|SNES - Profit before interest, taxes and amortization|Earnings per share for the last twelve months SenesTech|SNES - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months senestech.com|SNES - Expected net earnings per share growth this year|Earnings growth forecast for next year SenesTech, Inc.

- total revenue and sales volume data:

SNES - Revenue and Sales Volume|Projected Sales Volume SenesTech, Inc.|SNES - Price-to-Sales Ratio|Forward P/S Multiple SenesTech Inc.

Basic company analysis:SNES SenesTech

The scale of expansion for SenesTech, Inc. (SNES) is reflected through the projected volume of sales activity. This indicator synthesizes expert market expectations regarding the business's future cash inflows. The calculation is based on consensus revenue forecasts, revealing potential for commercial growth or hidden stagnation. For this bio-solutions developer, such dynamics confirm the resilience of inelastic B2B demand. The long-term trend determines the validity of the capitalization given the low capital intensity of production.

Who SenesTech, Inc. competes with